Epithelium-generated neuropeptide y induces smooth muscle contraction to promote airway hyperresponsiveness

Journal of Clinical Investigation

Volumn 126, Issue 5, 2016, Pages 1978-1982

  Li, Shanru ^a,b,c   Koziol White, Cynthia ^a,b   Jude, Joseph ^a,b   Jiang, Meiqi ^a,b   Zhao, Hengjiang ^a,b   Cao, Gaoyuan ^a,b   Yoo, Edwin ^a,b   Jester, William ^a,b   Morley, Michael P ^a,b,c   Zhou, Su ^a,b   Wang, Yi ^a,b,c   Lu, Min Min ^a,b   Panettieri, Reynold A ^a,b   Morrisey, Edward E ^a,b,c,d  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Cardiovascular Institute   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN LIGHT CHAIN; NEUROPEPTIDE Y; PROTEIN FOXP1; PROTEIN FOXP4; RHO KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, MOUSE; FOXP4 PROTEIN, MOUSE; REPRESSOR PROTEIN;

AIRWAY SMOOTH MUSCLE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; ECTOPIC EXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT ALLERGY; SMOOTH MUSCLE CONTRACTION; ANIMAL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY MUCOSA; SMOOTH MUSCLE;

ANIMALS; ASTHMA; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSIN LIGHT CHAINS; NEUROPEPTIDE Y; REPRESSOR PROTEINS; RESPIRATORY MUCOSA; RHO-ASSOCIATED KINASES;

EID: 84988487544     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81389     Document Type: Article

References (31)

1. Douwes J, Gibson P, Pekkanen J, Pearce N. Noneosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57(7):643-648.
2. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc. 2009;6(3):256-259.
3. Li S, et al. Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2. Development. 2012;139(14):2500-2509.
4. Amrani Y, et al. Expression and activation of the oxytocin receptor in airway smooth muscle cells: regulation by TNFα and IL-13. Respir Res. 2010;11:104.
5. Banerjee A, et al. Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. Am J Respir Cell Mol Biol. 2012;46(2):132-138.
6. Cooper PR, Panettieri RA Jr. Steroids completely reverse albuterol-induced [beta]2-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol. 2008;122(4):734-740.
7. Crapo RO, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
8. Mays LE, et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. J Clin Invest. 2013;123(3):1216-1228.
9. Ghosh S, et al. B lymphocytes regulate airway granulocytic inflammation cytokine production in a murine model of fungal allergic asthma. Cell Mol Immunol. 2015;12(2):202-212.
10. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982;296(5858):659-660.
11. Higuchi H, Yang HY, Sabol SL. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem. 1988;263(13):6288-6295.
12. Ericsson A, Hemsen A, Lundberg JM, Persson H. Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res. 1991;192(2):604-611.
13. Zukowska-Grojec Z, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83(2):187-195.
14. Dimitrijevic M, Stanojevic S. The intriguing mission of neuropeptide Y in the immune system. Amino Acids. 2013;45(1):41-53.
15. Branchek TA, Gershon MD. Time course of expression of neuropeptide Y, calcitonin generelated peptide, and NADPH diaphorase activity in neurons of the developing murine bowel and the appearance of 5-hydroxytryptamine in mucosal enterochromaffin cells. J Comp Neurol. 1989;285(2):262-273.
16. Macia L, Rao PT, Wheway J, Sierro F, Mackay F, Herzog H. Y1 signalling has a critical role in allergic airway inflammation. Immunol Cell Biol. 2011;89(8):882-888.
17. Wheway J, Herzog H, Mackay F. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem. 2007;7(17):1743-1752.
18. Jaakkola U, et al. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects - the cardiovascular risk in young Finns study. Neuropeptides. 2012;46(6):321-328.
19. Makinde TO, Steininger R, Agrawal DK. NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma. Exp Mol Pathol. 2013;94(1):45-50.
20. Erle DJ, Sheppard D. The cell biology of asthma. J Cell Biol. 2014;205(5):621-631.
21. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol. 1985;25:593-620.
22. Amrani Y, Da Silva A, Kassel O, Bronner C. Biphasic increase in cytosolic free calcium induced by bradykinin and histamine in cultured tracheal smooth muscle cells: is the sustained phase artifactual? Naunyn Schmiedebergs Arch Pharmacol. 1994;350(6):662-669.
23. Bradding P. Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol. 2008;4(2):84-90.
24. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45-56.
25. Wu ZX, Benders KB, Hunter DD, Dey RD. Early postnatal exposure of mice to side-steam tobacco smoke increases neuropeptide Y in lung. Am J Physiol Lung Cell Mol Physiol. 2012;302(1):L152-L159.
26. Voedisch S, Rochlitzer S, Veres TZ, Spies E, Braun A. Neuropeptides control the dynamic behavior of airway mucosal dendritic cells. PLoS One. 2012;7(9):e45951.
27. Dahlof C, Dahlof P, Lundberg JM, Strombom U. Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma. Pulm Pharmacol. 1988;1(1):3-6.
28. Cardell LO, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J. 1994;7(12):2169-2173.
29. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 1996;381(6581):415-421.
30. Bates D, Machler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1-48.
31. Halekoh U, Hojsgaard S. Kenward-Roger approximation and parametric bootstrap methods for tests in linear mixed models - The R Package pbkrtest. J Stat Softw. 2014;59(9):1-32.